BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 14160537)

  • 1. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 2. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 3. [60 YEARS OF FIBRINOLYSIS].
    MARCHAL G
    Hemostase; 1963; 3():101-4. PubMed ID: 14050807
    [No Abstract]   [Full Text] [Related]  

  • 4. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 5. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 6. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 7. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 8. [RESEARCH ON THE ENZYMATIC ACTIVITIES OF PLASMIN AND STREPTOKINASE].
    VAUXSAINT CYR
    Biol Med (Paris); 1963; 52():611-30. PubMed ID: 14095161
    [No Abstract]   [Full Text] [Related]  

  • 9. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
    HIRATA T
    Kobe Ika Daigaku Kiyo; 1963 Dec; 25():1-9. PubMed ID: 14117791
    [No Abstract]   [Full Text] [Related]  

  • 10. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 11. THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. I. FUNCTIONAL PROPERTIES OF THE ACTIVATED ENZYME.
    MARKUS G; WERKHEISER WC
    J Biol Chem; 1964 Aug; 239():2637-43. PubMed ID: 14235547
    [No Abstract]   [Full Text] [Related]  

  • 12. A METHOD FOR ASSESSING CLOT LYSIS.
    HOWELL M
    J Clin Pathol; 1964 May; 17(3):310-2. PubMed ID: 14159468
    [No Abstract]   [Full Text] [Related]  

  • 13. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 14. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS.
    MCNICOL GP; DOUGLAS AS
    Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764
    [No Abstract]   [Full Text] [Related]  

  • 15. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 16. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 17. [LEUKOCYTIC FIBRINOLYSIS].
    CAVIEZEL O; VOLLERY M; VANNOTTI A
    Schweiz Med Wochenschr; 1964 Jul; 94():1016-20. PubMed ID: 14243603
    [No Abstract]   [Full Text] [Related]  

  • 18. POSTOPERATIVE CHANGES IN THE COAGULATION FACTORS AND THE FIBRINOLYTIC SYSTEM.
    OLOW B
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:30-3. PubMed ID: 14199706
    [No Abstract]   [Full Text] [Related]  

  • 19. HEPARIN FRACTIONATION IN THE STUDY OF LYTIC ACTIVITY.
    GREEN J
    J Clin Pathol; 1964 May; 17(3):316-8. PubMed ID: 14159470
    [No Abstract]   [Full Text] [Related]  

  • 20. ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS.
    O'CONNELL RA; GROSSI CE; ROUSSELOT LM
    Lancet; 1964 Nov; 2(7367):990-1. PubMed ID: 14201669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.